Randomized Trial of Trimethoprim-Sulfamethoxazole versus Pyrimethamine-Sulfadiazine for Therapy of Toxoplasmic Encephalitis in Patients with AIDS
- 1 June 1998
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 42 (6) , 1346-1349
Abstract
The aim of the present pilot study was to compare the efficacy and safety of trimethoprim (TMP) and sulfamethoxazole (SMX) with those of the standard therapy pyrimethamine (P)-sulfadiazine (S) for the treatment of toxoplasmic encephalitis in patients with AIDS. This was a pilot, multicenter, randomized, and prospective study. Patients were randomly assigned to receive TMP (10 mg/kg of body weight/day) and SMX (50 mg/kg/day) or P (50 mg daily) and S (60 mg/kg/day) as acute therapy (for 4 weeks) and then as maintenance therapy for 3 months at half of the original dosage. Seventy-seven patients were enrolled and randomized to the study: 40 patients were treated with TMP-SMX and 37 were treated with P-S. There was no statistically significant difference in clinical efficacy during acute therapy. In contrast, patients randomized to TMP-SMX appeared more likely to achieve a complete radiologic response after acute therapy. Adverse reactions were significantly more frequent in patients treated with P-S, and skin rash was the most common adverse event noted in these patients. In conclusion, the results of the study suggest that TMP-SMX appears to be a valuable alternative to P-S, in particular in patients with opportunistic bacterial infections.Keywords
This publication has 22 references indexed in Scilit:
- Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patientsAntimicrobial Agents and Chemotherapy, 1995
- Toxoplasmic Encephalitis in AIDSClinical Infectious Diseases, 1992
- Toxoplasma Encephalitis in Patients with the Acquired Immunodeficiency SyndromeMedicine, 1992
- Cotrimoxazole therapy ofToxoplasma gondii encephalitis in AIDS patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Central nervous system toxoplasmosis in AIDS patientsAIDS, 1990
- Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndromeThe American Journal of Medicine, 1989
- Toxoplasmic EncephalitisThe Journal of Infectious Diseases, 1988
- Use of Trimethoprim-Sulfamethoxazole Singly and in Combination with Other Antibiotics in Immunocompromised PatientsClinical Infectious Diseases, 1987
- Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience at UCSF and review of the literatureJournal of Neurosurgery, 1985
- Cerebrospinal fluid concentrations of trimethoprim during oral and parenteral treatmentJournal of Antimicrobial Chemotherapy, 1979